The U.S. Defense Department said it awarded on January 7 a contract to Revival Health Inc. for 13.3 million COVID-19 at-home test kits as part of President Joe Biden’s plan to make available 500 million test kits.
The U.S. Centers for Disease Control and Prevention (CDC) on January 4 backed the agency’s week-old guidance for people seeking to end their COVID-19 isolation at five days, adding they could take a rapid antigen test if they want to and can access one, but is not requiring that.
Elizabeth Holmes is facing decades in prison after a jury found the founder and former chief executive officer of the blood-testing company Theranos guilty of four fraud charges.
President Joe Biden on December 27 pledged to ease a shortage of Covid-19 tests as the Omicron variant threatened to overwhelm hospitals and stifle travel plans as it spreads across the United States during the holiday week.
Laboratory analysis of the antibody-based Covid-19 therapy GlaxoSmithKline is developing with U.S. partner Vir Biotechnology indicated the drug is effective against the new Omicron variant, the British drugmaker said on December 2.
Glympse Bio has developed a liquid biopsy with the potential to diagnose and monitor non-alcoholic steatohepatitis (NASH) with significantly higher accuracy and less invasiveness than needle biopsies, according to a late-breaking presentation at the American Association for the Study of Liver Disease (AASLD) annual The Liver Meeting.
A unit of Abbott Laboratories is recalling two Covid-19 laboratory test kits as they can potentially issue false positive results, the U.S. Food and Drug Administration said on Oct. 14.
Australian scientists say they have developed the “holy grail” of blood sugar testing for diabetics, a non-invasive strip that checks glucose levels via saliva.
On the cusp of the 2021 American Society of Clinical Oncology meeting, more companies are announcing data presentations that will be made over the four-day conference as BioSpace continues to take a look at some of the data that will be shared.
Abbott received U.S. Food and Drug Administration Emergency Use Authorization (EUA) for over-the-counter, non-prescription, asymptomatic use of the company’s BinaxNOW COVID-19 Ag Self Test for detection of COVID-19 infection.
